文献速递癫痫

MAST3 STK域致病变异与癫痫相关

Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy.
PubMed 文献 · Ann Neurol · 2021-07-13

该研究通过外显子测序在癫痫患者中鉴定MAST3错义变异,并在HEK293T细胞中评估其对ARPP-16磷酸化的影响。11例携带STK域新发错义变异者均患发育性及癫痫性脑病,体外实验提示变异可能导致MAST3功能获得。MAST3表达局限于产前晚期及出生后皮层的兴奋性神经元。

要点

  • MAST3 STK域新发错义变异可致发育性及癫痫性脑病。
  • 多数患者出现多种发作类型、发热诱发及耐药性癫痫。
  • 体外实验提示该变异可能为MAST3功能获得机制。

核心结论

  • MAST3是新的癫痫相关基因,致病机制可能为功能获得,且可能主要局限于皮层兴奋性神经元。

研究设计与样本

  • 采用外显子测序在癫痫个体中鉴定MAST3错义变异。
  • 在HEK293T细胞中评估变异对MAST3磷酸化靶基因产物ARPP-16的影响。
  • 采用单核RNA测序和免疫组化观察MAST3表达。

主要发现

  • 在11例个体中鉴定STK域新发错义变异,包括2个复发性变异p.G510S(n=5)和p.G515S(n=3)。
  • 11例均有发育性及癫痫性脑病,8例在<2岁起病前发育正常。
  • 所有患者出现多种发作类型,9/11患者有发热诱发发作,9/11患者有耐药性癫痫。
  • 转染患者特异性错义变异MAST3 cDNA的HEK293T细胞显示表达量可变但总体降低,同时MAST3靶点ARPP-16磷酸化增加。
  • MAST3表达局限于产前晚期及出生后皮层的兴奋性神经元。

关键数值与推荐

  • 11例均携带STK域新发错义变异,其中p.G510S为5例、p.G515S为3例。
  • 8/11患者在<2岁起病前发育正常。
  • 9/11患者有发热诱发发作,9/11患者有耐药性癫痫。

临床怎么用

  • 对发育性及癫痫性脑病、早发起病、发热诱发及耐药性癫痫患者,可考虑MAST3相关癫痫的基因检测。
  • MAST3变异的功能学提示功能获得机制,但尚无靶向治疗推荐。

局限性

  • 体外HEK293T细胞实验仅检测部分患者特异性变异,功能改变呈可变但总体表达降低。
  • 样本量有限,未提供长期随访或治疗反应数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The MAST family of microtubule-associated serine-threonine kinases (STKs) have distinct expression patterns in the developing and mature human and mouse brain. To date, only MAST1 has been conclusively associated with neurological disease, with de novo variants in individuals with a neurodevelopmental disorder, including a mega corpus callosum. METHODS: Using exome sequencing, we identify MAST3 missense variants in individuals with epilepsy. We also assess the effect of these variants on the ability of MAST3 to phosphorylate the target gene product ARPP-16 in HEK293T cells. RESULTS: We identify de novo missense variants in the STK domain in 11 individuals, including 2 recurrent variants p.G510S (n = 5) and p.G515S (n = 3). All 11 individuals had developmental and epileptic encephalopathy, with 8 having normal development prior to seizure onset at <2 years of age. All patients developed multiple seizure types, 9 of 11 patients had seizures triggered by fever and 9 of 11 patients had drug-resistant seizures. In vitro analysis of HEK293T cells transfected with MAST3 cDNA carrying a subset of these patient-specific missense variants demonstrated variable but generally lower expression, with concomitant increased phosphorylation of the MAST3 target, ARPP-16, compared to wild-type. These findings suggest the patient-specific variants may confer MAST3 gain-of-function. Moreover, single-nuclei RNA sequencing and immunohistochemistry shows that MAST3 expression is restricted to excitatory neurons in the cortex late in prenatal development and postnatally. INTERPRETATION: In summary, we describe MAST3 as a novel epilepsy-associated gene with a potential gain-of-function pathogenic mechanism that may be primarily restricted to excitatory neurons in the cortex. ANN NEUROL 2021;90:274-284.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Spinelli E, Christensen KR, Bryant E, et al. Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy. Ann Neurol. 2021. PMID: 34185323. doi:10.1002/ana.26147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。